News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,270 Results
Type
Article (2384)
Company Profile (44)
Press Release (34842)
Section
Business (14089)
Career Advice (76)
Deals (2070)
Drug Delivery (8)
Drug Development (4077)
Employer Resources (10)
FDA (426)
Job Trends (756)
News (20081)
Policy (1050)
Tag
Academia (143)
Alliances (3442)
Alzheimer's disease (41)
Approvals (425)
Bankruptcy (10)
Best Places to Work (472)
Biosimilars (9)
Biotechnology (33)
Breast cancer (11)
Cancer (76)
Career advice (64)
CAR-T (7)
Cell therapy (23)
Clinical research (3075)
Collaboration (43)
Compensation (22)
COVID-19 (179)
C-suite (16)
Data (54)
Diagnostics (457)
Earnings (4135)
Employer resources (8)
Events (5840)
Executive appointments (39)
FDA (446)
Funding (43)
Gene editing (10)
Gene therapy (7)
GLP-1 (52)
Government (146)
Healthcare (696)
Infectious disease (181)
Inflammatory bowel disease (10)
Intellectual property (7)
IPO (970)
Job creations (289)
Job search strategy (62)
Layoffs (31)
Legal (210)
Lung cancer (10)
Manufacturing (11)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1127)
Metabolic disorders (18)
Neuroscience (67)
NextGen Class of 2024 (349)
Non-profit (153)
Northern California (212)
Obesity (7)
Opinion (13)
Patents (10)
People (5522)
Phase I (1318)
Phase II (1554)
Phase III (822)
Pipeline (29)
Policy (7)
Postmarket research (30)
Preclinical (576)
Radiopharmaceuticals (11)
Rare diseases (8)
Real estate (419)
Regulatory (771)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (8)
Series A (9)
Southern California (208)
Startups (485)
United States (1002)
Vaccines (19)
Weight loss (7)
Date
Today (6)
Last 7 days (58)
Last 30 days (289)
Last 365 days (2668)
2024 (2439)
2023 (2857)
2022 (3751)
2021 (4049)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (42)
Arizona (13)
Asia (1820)
Australia (293)
California (473)
Canada (84)
China (20)
Colorado (9)
Connecticut (8)
Europe (3751)
Florida (26)
Illinois (12)
Indiana (19)
Kansas (12)
Maryland (17)
Massachusetts (161)
Minnesota (12)
New Jersey (25)
New York (32)
North Carolina (71)
Northern California (212)
Ohio (20)
Pennsylvania (20)
South America (40)
Southern California (208)
Texas (36)
Washington State (22)
37,270 Results for "nexcelom bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ampersand Completes Sale of Portfolio Company Nexcelom Bioscience to PerkinElmer
Ampersand Capital Partners announced that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash.
June 25, 2021
·
2 min read
Deals
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience
PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash.
May 12, 2021
·
6 min read
Press Releases
Rigaku BioScience Lab Opens in USA
November 21, 2024
·
3 min read
Press Releases
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
November 21, 2024
·
1 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Press Releases
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
October 15, 2024
·
5 min read
Press Releases
LIfT BioSciences expands into Ireland for manufacturing & clinical operations
November 18, 2024
·
5 min read
Press Releases
Solid Biosciences to Present at the Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Policy
Yield10 Bioscience Announces Delisting from Nasdaq
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that Company has received a final delisting notice from Nasdaq.
May 15, 2024
·
3 min read
1 of 3,727
Next
